Media "Classics"

Media "Classics" (8)

The best write-ups on Cytori from the past.

Friday, 13 April 2012 11:33

The Analyst´s view

Written by
On January 24, 2010 Joe Feshbach (picture- here with his wife Cindy) published an article on his Instablog at Seeking Alpha, written by his friend, former investment banker and author of the book "Lost Star of Myth and Time"- Walter Cruttenden. An absolute classic for believers in Cytori technology. Joe was one of those believers and after attending the first…
Last modified on Monday, 22 February 2016 11:42
Friday, 13 April 2012 06:45

A Conversation with Chris Calhoun

Written by
Written by Daniel Fromson Cytori Therapeutics probably ranks somewhere near the top of any list of the world's most innovative medical technology companies--or at least a list of its boldest. As CEO Christopher J. Calhoun explains, the company aims to do nothing less than revolutionize health care by leading the way into an era of regenerative medicine, in which damage…
Last modified on Monday, 22 February 2016 11:10
Thursday, 12 April 2012 14:05

Sharon Begley´s "Wired" Part I

Written by
On this spring afternoon, the 44-year-old CEO of San Diego- based biotech company Cytori Therapeutics pulls out his laptop, launches a PowerPoint presentation, and there they are: conical and cantaloupy. As through Ds, beige and pink and taupe and tan, more breasts than you might see in a women's locker room, never mind in the middle of a lunch table.…
Last modified on Monday, 22 February 2016 11:13
Thursday, 12 April 2012 14:42

Sharon Begley´s "Wired"- Part II

Written by
Part II- "These things have gone through the ringer in choosing a name," says biomechan-ical engineer Kent Leach of UC Davis, who has used whatever-they-are to treat bone cysts in racehorses. A stem cell, by definition, is able to differentiate into any of the 200-plus kinds of cells in the human body, just as the cells of a days-old embryo…
Last modified on Monday, 22 February 2016 11:12
Saturday, 14 April 2012 16:45

Sign-on SD: Stem Cells from Fat

Written by
San Diego's Cytori banks on a new process to help damaged hearts Getting rid of that spare tire around your middle could help your heart in more ways than you might expect, according to a San Diego biotechnology company. Cytori Therapeutics has developed a machine that pulls stem cells and other regenerative cells out of fat so they can be…
Last modified on Monday, 22 February 2016 10:56
Tuesday, 17 April 2012 06:50

CYTX: a Low Risk Stem Cell Play

Written by
The biotech company has had successful clinical trials yet is unloved by the market. Here's why investors should start a position now. Written by James Anderson Typically, early-stage biotech companies are considered to have a binary outcome. If successful with the first product that enters clinical trials the company moves on to raise more money through stock sales, enter a…
Last modified on Monday, 22 February 2016 10:53
Tuesday, 18 December 2012 11:55

Bioworld- Cytori Fattens Its Coffers

Written by
  I found this article in my mailbox yesterday, which appeared on the respected BioWorld Daily Biopharmaceutical News Site, written by Mr. R. Osborne. I think it has some positive statements, which other Cytori shareholders should also be able to take note of-   Cytori Fattens Coffers: $18.5M for Adipose Stem Cell Efforts BioWorld Today By Randy Osborne 17 December…
Last modified on Tuesday, 23 February 2016 09:09
Sunday, 23 December 2012 13:27

Jason dines with prominent SC cardiologists

Written by
  My mailbox has been overflowing off-late with messages of unhappy investors in the Cytori stock. A few days ago, however there was finally a message again with an attachment, that was very positive and worth sharing with the other folks. The report by Jason Kolbert of Maxim´s of his dinner meeting with some leading cardiologists in San Francisco was…
Last modified on Friday, 26 February 2016 05:05

Copyright Information

Copyright Fas Kuiters © 2016 All Rights Reserved.
This page is made with Joomla CMS and its various templates designed by Fas Kuiters with the excellent Themler tool.



Shared Spreadsheet Links

DOV´s Revised Projections for the Periods 2017 until 2020

Shareble link : HERE

Fas Kuiters Websites